Dallas, TX – According to filings with the U.S. Securities and Exchange Commission, Instil Bio is raising $185,449,881.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Bronson Crouch played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Instil Bio

Instil Bio, Inc is a global, clinical-stage cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of cancer. We are building on the decades-long foundation of TIL efficacy in treating solid tumors, applying our cell therapy experience and TIL manufacturing platform to bring the promise of TIL therapy to patients in need. Instil Bio has research and cell therapy manufacturing facilities in Los Angeles, CA and Manchester, UK, with corporate offices in Dallas, TX.

To learn more about Instil Bio, visit http://instilbio.com/

Contact:
Bronson Crouch, Chief Executive Officer
240-676-3715
https://www.linkedin.com/in/bronson1/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved